Lineage Cell: 1Q Earnings Snapshot

May 7, 2020 GMT

CARLSBAD, Calif. (AP) _ Lineage Cell Therapeutics, Inc. (LCTX) on Thursday reported a first-quarter loss of $8.4 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Carlsbad, California-based company said it had a loss of 6 cents.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 5 cents per share.

The biotechnology company posted revenue of $514,000 in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $926,000.



This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LCTX at https://www.zacks.com/ap/LCTX